SCCM Resource Library-Subcutaneous Heparin Dose in Underweight Critically Ill Patients

Subcutaneous Heparin Dose in Underweight Critically Ill Patients

Video Transcription

Video Summary

Bernice, a Burn Surgical Critical Care Pharmacist, presented a study on the subcutaneous heparin dose in underweight critically ill patients. The study aimed to compare the outcomes of standard dose heparin (SDH) and dose-reduced heparin (DRH) in these patients. The retrospective study included 255 patients and found that in patients who received less than 15,000 units per day of heparin, there was a lower incidence of bleeding and no difference in new VTE, ICU and hospital length of stay, and in-hospital mortality compared to those who received higher doses. The findings suggest that dose-reduced heparin may be reasonable for VTE prophylaxis in underweight critically ill patients.

Asset Subtitle

Pharmacology, 2023

Asset Caption

Type: star research | Star Research Presentations: Pharmacology II (SessionID 30016)

Meta Tag

Content Type Presentation

Knowledge Area Pharmacology

Membership Level Professional

Membership Level Select

Tag Anticoagulation

Year 2023

Keywords

subcutaneous heparin dose

underweight critically ill patients

dose-reduced heparin

retrospective study

VTE prophylaxis

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.